Potency and hourly maintenance requirement of combinations of mivacurium and pancuronium in adults

Canadian Journal of Anaesthesia

Volumn 45, Issue 3, 1998, Pages 212-216

  Rautoma, Pekka ^a,c   Erkola, Olli ^a   Meretoja, Olli A ^b  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c Maria Hospital   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ALFENTANIL; MIVACURIUM; NEOSTIGMINE; NITROUS OXIDE; OXYGEN; PANCURONIUM; PROPOFOL;

ADOLESCENT; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG MIXTURE; DRUG POTENCY; DRUG POTENTIATION; HUMAN; NEUROMUSCULAR BLOCKING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0031776398     PISSN: 0832610X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03012904     Document Type: Article

References (16)

1. Bevan DR, Smith CE, Donati F. Postoperative neuromuscular blockade: a comparison between atracurium, vecuronium, and pancuronium. Anesthesiology 1988; 69: 272-6.
2. Viby-Mogensen J, Jorgensen BC, Ørding H. Residual curarization in the recovery room. Anesthesiology 1979; 50: 539-41.
3. Savarese JJ, Ali HH, Basta SJ, et al. The clinical neuromuscular pharmacology of mivacurium chloride (BW B109OU). Anesthesiology 1988; 68: 723-32.
4. Erkola O, Rautoma P, Meretoja OA. Mivacurium when preceded by pancuronium becomes a long-acting muscle relaxant. Anesthesiology 1996; 84: 562-5.
5. Rautoma P, Erkola O, Meretoja OA. Synergism between mivacurium and pancuronium in adults. Acta Anaesthesiol Scand 1995; 39: 733-7.
6. Donlon JV Jr, Savarese JJ, Ali HH, Teplik RS. Human dose-response curves for neuromuscular blocking drugs: a comparison of two methods of construction and analysis. Anesthesiology 1980; 53: 161-6.
7. Meretoja OA, Wirtavuori K. Two-dose technique to create an individual dose-response curve for atracurium. Anesthesiology 1989; 70: 732-6.
8. Meretoja OA, Brandom BW, Taivainen T, Jalkanen L. Synergism between atracurium and vecuronium in children. Br J Anaesth 1993; 71: 440-2.
9. Ali HH, Savarese JJ, Embree PB, et al. Clinical pharmacology of mivacurium chloride (BW B109OU) infusion: comparison with vecuronium and atracurium. Br J Anaesth 1988; 61: 541-6.
10. Brandom BW, Meretoja OA. Dose-response calculations revisited (Letter). Anesth Analg 1994; 78: 608-9.
11. Brandom BW, Meretoja OA, Taivainen T, Wirtavuori K. Accelerated onset and delayed recovery of neuromuscular block induced by mivacurium preceded by pancuronium in children. Anesth Analg 1993; 76: 998-1003.
12. Meretoja OA. Neuromuscular blocking agents in paediatric patients: influence of age on the response. Anesth Intensive Care 1990; 18: 440-8.
13. Whalley DG, Lewis B, Bedocs NM. Recovery of neuromuscular function after atracurium and pancuronium maintenance of pancuronium block. Can J Anaesth 1994; 41: 31-5.
14. Stinson LW Jr, Lanier WL, Lennon RL. Train-of-four recovery after pharmacologic antagonism of pancuronium-, pipecuronium-, and doxacurium-induced neuromuscular block in anaesthetized humans. Acta Anaesthesiol Scand 1995; 23: 406-10.
15. Waud BE, Waud DR. Interaction among agents that block end-plate depolarization competitively. Anesthesiology 1985; 63: 4-15.
16. Stovner J, Oftedal N, Holmboe J. The inhibition of cholinesterases by pancuronium. Br J Anaesth 1975; 47: 949-54.